In short. Two answers decide the plan: which cause is present, and how deep the change sits. What the history and examination establish, and why depth rules rungs in or out.
Key points
- Every product you currently use, or photographs of the labels, with how long you have used each and how often.
- A list of your medicines, including hormonal contraception and anything obtained without a prescription.
- Photographs taken in the same light and at the same distance over a few months.
The assessment of an uneven complexion is short, and it settles more than any product decision will. It answers two questions. Which category the unevenness belongs to: pigment, vessels or texture. And how deep the change sits, because depth decides whether a topical treatment is worth months or whether nothing short of a procedure will reach it.
The history does most of the work
When the unevenness began, and what else changed at the same time, is the first question. A pregnancy, a change in hormonal contraception, a new medicine, a period of intense sun or a course of acne all date a change in skin colour and point toward its cause. What has already been tried matters as much: how long each product was used, whether it was used consistently, and what happened while it was. A tendency for the skin to mark after a scratch predicts how that skin will behave after treatment.
What the examination looks at
Distribution comes first: whether the change sits on the areas that face the light, whether it is symmetric, and whether it sits where a lesion healed. The edges are read next, because defined and soft edges suggest different processes. Pressure is applied, to separate what blanches from what does not. The surface is then examined in raking light, since that is the only way to judge pores, creases and shallow scars.
Depth is estimated from all of this together with how the skin has behaved before. Pigment sitting high in the skin is usually browner, better defined and more responsive. Pigment sitting deeper is greyer or bluer, softer at the edges and largely beyond what topical treatment reaches. An earlier response to treatment is genuine evidence about depth.
What to bring to the assessment
Every product you currently use, or photographs of the labels, with how long you have used each and how often. A list of your medicines, including hormonal contraception and anything obtained without a prescription. Photographs taken in the same light and at the same distance over a few months.
When tests are needed
Where the history suggests a hormonal, thyroid, metabolic or medicine-related cause, or where the darkening is generalised rather than confined to the face, blood tests are arranged for a specific question rather than routinely. Where a mole or an unusual patch is found, the cosmetic plan stops and that lesion is dealt with first.
What the assessment is not
It is not a demonstration of a device. A plan chosen before the category and the depth are known is a guess with a recovery period attached. A proper assessment ends with a category, an estimate of depth, an order of steps, and a statement of the ceiling.
Findings that change the plan entirely
- A mole or spot that is changing, itching, bleeding or failing to heal.
- Darkening that is generalised, or that arrived suddenly or after a new medicine.
- Skin that is currently irritated, blistering or reacting to a product.
Frequently asked questions
Why does the assessment need to establish how deep the pigment sits?
Because depth is the strongest predictor of what treatment can achieve. Pigment held high in the skin is reachable by topical agents and by superficial work, and it usually fades. Pigment held deeper is greyer in tone, softer at the edges, and largely beyond what those approaches reach, so a deep pattern that is treated as though it were a surface one produces months of effort and almost no visible change.
Do I need any tests before treatment can start?
Usually not, but sometimes. Where the darkening is generalised rather than facial, or where the history points to a hormonal, thyroid, metabolic or medicine-related cause, blood tests are ordered for that specific question. Where a mole or an unusual patch is found, that lesion is assessed on its own before any cosmetic plan continues, and the cosmetic plan waits.
Should I stop my current products before being assessed?
Do not stop anything prescribed without asking, and do not start anything new in the weeks beforehand either. Bring everything you use, with how long you have used it and how often. Irritated skin is harder to read and behaves differently under treatment, so an assessment is more useful when the skin is in its ordinary state rather than reacting to something introduced the week before.
Risks & Limitations
- Uneven tone is not one condition. Pigment, vessels and texture answer to different treatment, and a plan built on the wrong category can produce no change however long it is continued.
- Pigment that has faded returns with further unprotected sun exposure, and melasma relapses when control lapses. Maintenance is part of the result rather than evidence that treatment failed.
- Melasma is the pattern where aggressive treatment can leave skin darker rather than lighter; rebound darkening after high-energy pigment work is a recognised outcome, not a rare accident.
- No treatment resets skin to a single uniform colour. Tone can be reduced and evened, and pigment held deep in the dermis responds poorly to everything available.
When to Seek Care
- A mole or spot that is changing in size, shape or colour, or that itches, bleeds or fails to heal — have it examined rather than lightened.
- Darkening that has developed over weeks rather than years, or that appeared away from skin exposed to the sun — seek medical assessment.
- Darkening with tiredness, weight change, cold intolerance or dizziness, which may point to a hormonal or metabolic cause.
- Darkening with yellowing of the eyes or skin, dark urine or pale stools — seek medical assessment promptly.
References & Further Reading
- American Academy of Dermatology (AAD) — patient guidance on pigmentation disorders
- International League of Dermatological Societies (ILDS) — global standards of care
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Dermatology Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.